1 min read · 14 May 2009
Ksplice, a developer of technology to install software updates while applications are running, has won $100,000 in startup capital, as part of the MIT $100K Entrepreneurship Competition. The company was formed by a group of MIT engineering grads.
3 min read · 14 May 2009
Cempra Pharmaceuticals Inc., a Chapel Hill, N.C.-based developer of anti-infectives, has raised $46 million in Series C funding. Quaker BioVentures led the round, and was joined by Devon Park Bioventures and return backers Aisling Capital, Intersouth Partners, Teachers’ Private Capital and investment banker I. Wistar Morris III. The company previously raised around $32 million.
4 min read · 14 May 2009
Streamazzo SA, a Paris-based provider of rich application software platforms for mobile, has raised €4 million in new VC funding. Innovacom led the round, and was joined by return backers Sofinnova Partners, Sofinnova Ventures, Qualcomm, NTEC and GET Valorisation.
3 min read · 14 May 2009
2 min read · 14 May 2009
Anulex Technologies Inc., a Minnetonka, Minn.-based maker of medical devices for spinal disk preservation and anular repair, has raised $10.2 million in fourth-round funding, according to a regulatory filing. It had previously raised around $34 million, from firms like Delphi Ventures, New Enterprise Associates, St. Paul Venture Capital, Affinity Capital Management, MB Venture Partners and SightLine Partners. It also secured a $7 million "growth capital term loan" from Silicon Valley Bank. www.anulex.com
1 min read · 13 May 2009
FUHU Inc., a provider of digital life applications like identity cards and widgets, has raised $6.25 million in Series B funding from Acer Inc. www.fuhu.com
1 min read · 13 May 2009
BlogHer, a New York-based online community "for women who blog," has raised $7 million in Series C funding, according to Kara Swisher. Azure Capital led the round, and was joined by return backers Peacock Equity and Venrock. The company has now raised around $15.5 million in total VC funding. www.blogher.com
1 min read · 13 May 2009
Metabolic Solutions Development Co., a Kalamazoo, Mich.-based developer of drugs to treat Type II diabetes, has raised $9.25 million in new VC funding. According to VentureWire, investors include Hopen Therapeutics and Southwest Michigan First Life Science. The company also secured $1.36 million in grants from the National Institutes of Health.
3 min read · 13 May 2009
1 min read · 13 May 2009
